Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $1.10 billion
- Book Value:
- Revenue TTM:
- $270.65 million
- Operating Margin TTM:
- Gross Profit TTM:
- $219.91 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Cellebrite DI had its IPO on 2021-08-31 under the ticker symbol CLBT.
The company operates in the Technology sector and Software-Infrastructure industry. Cellebrite DI has a staff strength of 0 employees.
Shares of Cellebrite DI opened at $5.77 at the start of the last trading session i.e. 2023-03-24.
The stocks traded within a range of $5.72 - $5.88, and closed at $5.86.
This is a +0.69% increase from the previous day's closing price.
A total volume of 153,629 shares were traded at the close of the day’s session.
In the last one week, shares of Cellebrite DI have increased by +0.51%.
Cellebrite DI's Key Ratios
Cellebrite DI has a market cap of $1.10 billion, indicating a price to book ratio of 13.6828 and a price to sales ratio of 3.0683.
In the last 12-months Cellebrite DI’s revenue was $270.65 million with a gross profit of $219.91 million and an EBITDA of $10.24 million. The EBITDA ratio measures Cellebrite DI's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Cellebrite DI’s operating margin was 0.39% while its return on assets stood at 0.18% with a return of equity of 46.64%.
In Q4, Cellebrite DI’s quarterly earnings growth was a negative -85.3% while revenue growth was a positive 9%.
Cellebrite DI’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0.59 per share while it has a forward price to earnings multiple of 37.1747 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cellebrite DI’s profitability.
Cellebrite DI stock is trading at a EV to sales ratio of 2.5216 and a EV to EBITDA ratio of 163.4949. Its price to sales ratio in the trailing 12-months stood at 3.0683.
Cellebrite DI stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $403.29 million
- Total Liabilities
- $207.78 million
- Operating Cash Flow
- Capital Expenditure
- $3.18 million
- Dividend Payout Ratio
Cellebrite DI ended 2023 with $403.29 million in total assets and $0 in total liabilities. Its intangible assets were valued at $403.29 million while shareholder equity stood at $73.87 million.
Cellebrite DI ended 2023 with $0 in deferred long-term liabilities, $207.78 million in other current liabilities, in common stock, $199.24 million in retained earnings and $26.83 million in goodwill. Its cash balance stood at $87.65 million and cash and short-term investments were $183.62 million. The company’s total short-term debt was $5,003,000 while long-term debt stood at $0.
Cellebrite DI’s total current assets stands at $295.93 million while long-term investments were $22.13 million and short-term investments were $95.98 million. Its net receivables were $78.76 million compared to accounts payable of $4.61 million and inventory worth $10.18 million.
In 2023, Cellebrite DI's operating cash flow was $0 while its capital expenditure stood at $3.18 million.
Comparatively, Cellebrite DI paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Cellebrite DI stock is currently trading at $5.86 per share. It touched a 52-week high of $7.31 and a 52-week low of $7.31. Analysts tracking the stock have a 12-month average target price of $7.48.
Its 50-day moving average was $5.5 and 200-day moving average was $4.95 The short ratio stood at 7.54 indicating a short percent outstanding of 0%.
Around 7686.2% of the company’s stock are held by insiders while 1830% are held by institutions.
Frequently Asked Questions About Cellebrite DI
Similar Industry Stocks (Software-Infrastructure)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company’s Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.